Pheroze Tamboli, MBBS

Peer-Reviewed Articles

1. Sangoi AR, Akgul M, Mubeen A, Humble R, Wu DJ, Pacheco R, Acosta A, Amin M, Aron M, Brimo F, Chan E, Cheng L, Cheville J, Collins K, Cornejo K, Dhillon J, Downes MR, Epstein JI, Hirsch M, Kapur P, Lobo A, Mehra R, Mohanty S, Netto G, Osunkoya AO, Paner G, Rao P, Saleeb R, Shah RB, Shen S, Smith S, Tickoo S, Tretiakova M, Trpkov K, Wobker S, Tamboli P, Zynger D, Williamson SR. Interobserver Reproducibility of Pelvicalyceal Invasion in Renal Cell Carcinoma Nephrectomies Among Genitourinary Pathologists. Am J Surg Pathol 49(12):1307-1314, 2025. e-Pub 2025. PMID: 40734292.
2. Ruiz-Cordero R, Wang Q, Kumar G, Akgul M, Creighton CJ, Rao P, Tamboli P, Zheng L, Zhao J, Murugan P, Shen S, Brimo F, Ezhilarasan R, Sulman E, Wani K, Lazar AJ, Kim T, Chen K, Bhat KPL, Kannan K, Wang J, Karam JA, Sircar K. Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples. Eur Urol Oncol 8(6):1629-1638, 2025. e-Pub 2025. PMID: 41193273.
3. Wu, DX, Akgul, M, Williamson, SR, Pacheco, R, Acosta, A, Al-Obaidy, KI, Amin, MB, Berney, D, Brimo, F, Cheng, L, Colecchia, M, Comperat, EM, Cornejo, KM, Dhillon, J, Downes, MR, Epstein, J, Hirsch, M, Jimenez, R, Kaushal, S, Lobo, A, Lopez-Beltran, A, Mehra, R, Mohanty, SK, Paner, GP, Rao, P, Reuter, V, Shah, RB, Shen, S, Smith, SC, Tretiakova, M, Trpkov, K, Wobker, SE, Tamboli, P, Zynger, DL, Sangoi, AR. Interobserver reproducibility of hilar soft tissue invasion in testicular germ cell tumours among genitourinary pathologists. Histopathology 87(5):677-686, 2025. e-Pub 2025. PMID: 40611804.
4. Menon S, Sanchez DF, Chaux A, Giannico GA, Oliveira P, Necchi A, Regauer S, Speiss PE, Tamboli P, Tsuzuki T, Elsa F V, Kristiansen G, Cheng L, Cubilla A. International Society of Urological Pathology (ISUP) Multidisciplinary Consensus on Premalignant and Putative Precursor Lesions of Penile Cancer: Working Group 5 report on Terminology, Grading, and Molecular Testing Practices. Am J Surg Pathol, 2025. e-Pub 2025. PMID: 40826809.
5. Moussa, MJ, Khandelwal, J, Wilson, NR, Malikayil, KL, Surasi, DS, Bathala, TK, Lin, Y, Rao, P, Tamboli, P, Sircar, K, Ajufo, HO, Elsayes, KM, Shah, AY, Johns, AC, Goswami, S, Hasanov, E, Jonasch, E, Msaouel, P, Campbell, M, Alhalabi, O, Tannir, NM. Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma. Journal for immunotherapy of cancer 13(2), 2025. e-Pub 2025. PMID: 39939142.
6. Bhat, P, Tamboli, P, Sircar, K, Kannan, KS. Spatial Distribution of Tumor Cells in Clear Cell Renal Cell Carcinoma Is Associated with Metastasis and a Matrisome Gene Expression Signature. Cancers 17(2), 2025. e-Pub 2025. PMID: 39858031.
7. Falahkheirkhah K, Guo T, Hwang M, Tamboli P, Wood CG, Karam JA, Sircar K, Bhargava R. A generative adversarial approach to facilitate archival-quality histopathologic diagnoses from frozen tissue sections. Lab Invest 102(5):554-559, 2022. e-Pub 2021. PMID: 34963688.
8. Tsai CW, Chang WS, Xu Y, Huang M, Tamboli P, Wood CG, Bau DT, Gu J. Prognostic significance of circulating insulin growth-like factor 1 and insulin growth-like factor binding protein 3 in renal cell carcinoma patients. Am J Cancer Res 12(2):852-860, 2022. e-Pub 2022. PMID: 35261807.
9. Wilson NR, Wiele AJ, Surasi DS, Rao P, Sircar K, Tamboli P, Shah AY, Genovese G, Karam JA, Wood CG, Tannir NM, Msaouel P. Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma. Clin Genitourin Cancer 19(6):e401-e408, 2021. e-Pub 2021. PMID: 34625389.
10. Kokorovic A, Duplisea J, Qiao W, McCormick B, Adibi M, Papadopoulos J, Ramirez G, Rao P, Tamboli P, Pettaway C. Oncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience. Urol Oncol 39(5):302.e19-302.e27, 2021. e-Pub 2021. PMID: 33612354.
11. Cowman SJ, Fuja DG, Liu XD, Tidwell RSS, Kandula N, Sirohi D, Agarwal AM, Emerson LL, Tripp SR, Mohlman JS, Stonhill M, Garcia G, Conley CJ, Olalde AA, Sargis T, Ramirez-Torres A, Karam JA, Wood CG, Sircar K, Tamboli P, Boucher K, Maughan B, Spike BT, Ho TH, Agarwal N, Jonasch E, Koh MY. Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer. Clin Cancer Res 26(18):4970-4982, 2020. e-Pub 2020. PMID: 32586940.
12. Huang T, Cheng X, Chahoud J, Sarhan A, Tamboli P, Rao P, Guo M, Manyam G, Zhang L, Xiang Y, Han L, Shang X, Deng P, Luo Y, Lu X, Feng S, Ferrer MM, Alan Wang Y, DePinho RA, Pettaway CA, Lu X. Effective combinatorial immunotherapy for penile squamous cell carcinoma. Nat Commun 11(1):2124, 2020. e-Pub 2020. PMID: 32358507.
13. Ruiz-Cordero R, Rao P, Li L, Qi Y, Atherton D, Peng B, Singh RR, Kim TB, Kawakami F, Routbort MJ, Alouch N, Chow CB, Tang X, Lu W, Brimo F, Matin SF, Wood CG, Tannir NM, Wistuba II, Chen K, Wang J, Medeiros LJ, Karam JA, Tamboli P, Sircar K. Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma. Mod Pathol 32(11):1698-1707, 2019. e-Pub 2019. PMID: 31231128.
14. Yu KJ, Keskin SK, Meissner MA, Petros FG, Wang X, Borregales LD, Gu C, Tamboli P, Matin SF, Wood CG, Karam JA. Renal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging. Cancer 124(20):4023-4031, 2018. e-Pub 2018. PMID: 30276798.
15. Petros FG, Metcalfe MJ, Yu KJ, Keskin SK, Fellman BM, Chang CM, Gu C, Tamboli P, Matin SF, Karam JA, Wood CG. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience. World J Urol 36(7):1093-1101, 2018. e-Pub 2018. PMID: 29488096.
16. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WY, Robertson AG, Research Network CGA, Spellman PT, Rathmell WK, Linehan WM. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep 23(12):3698, 2018. e-Pub 2018. PMID: 29925010.
17. Williamson SR, Rao P, Hes O, Epstein JI, Smith SC, Picken MM, Zhou M, Tretiakova MS, Tickoo SK, Chen YB, Reuter VE, Fleming S, Maclean FM, Gupta NS, Kuroda N, Delahunt B, Mehra R, Przybycin CG, Cheng L, Eble JN, Grignon DJ, Moch H, Lopez JI, Kunju LP, Tamboli P, Srigley JR, Amin MB, Martignoni G, Hirsch MS, Bonsib SM, Trpkov K. Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists. Am J Surg Pathol. e-Pub 2018. PMID: 29878933.
18. Petros FG, Keskin SK, Yu KJ, Li R, Metcalfe MJ, Fellman BM, Chang CM, Gu C, Tamboli P, Matin SF, Karam JA, Wood CG. Intraoperative Conversion From Partial to Radical Nephrectomy: Incidence, Predictive Factors, and Outcomes. Urology 116:114-119, 2018. e-Pub 2018. PMID: 29578041.
19. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WY, Robertson AG, Research Network CGA, Spellman PT, Rathmell WK, Linehan WM. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep 23(1):313-326.e5, 2018. e-Pub 2018. PMID: 29617669.
20. Wood EL, Adibi M, Qiao W, Brandt J, Zhang M, Tamboli P, Matin SF, Wood CG, Karam JA. Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses. J Urol 199(2):393-400, 2018. e-Pub 2018. PMID: 28941919.
21. Zhang M, Adeniran AJ, Vikram R, Tamboli P, Pettaway C, Bondaruk J, Liu J, Baggerly K, Czerniak B. Carcinoma of the Urethra. Hum Pathol 72:35-44, 2018. e-Pub 2018. PMID: 28827100.
22. Murugan P, Rao P, Tamboli P, Czerniak B, Guo CC. Primary Ewing Sarcoma / Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic Study of 23 Cases. Pathol Oncol Res 24(1):153-159, 2018. e-Pub 2018. PMID: 28429277.
23. Kawakami F, Sircar K, Rodriguez-Canales J, Fellman BM, Urbauer DL, Tamboli P, Tannir NM, Jonasch E, Wistuba II, Wood CG, Karam JA. Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation. Cancer 123(24):4823-4831, 2017. e-Pub 2017. PMID: 28832979.
24. Shah AY, Karam JA, Malouf GG, Rao P, Lim ZD, Jonasch E, Xiao L, Gao J, Vaishampayan UN, Heng DY, Plimack ER, Guancial EA, Fung C, Lowas SR, Tamboli P, Sircar K, Matin SF, Kimryn Rathmell W, Wood CG, Tannir NM. Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study. BJU Int 120(6):782-792, 2017. e-Pub 2017. PMID: 27860149.
25. Wang Z, Kim TB, Peng B, Karam J, Creighton C, Joon A, Kawakami F, Trevisan P, Jonasch E, Chow CW, Canales JR, Tamboli P, Tannir N, Wood C, Monzon F, Baggerly K, Varella-Garcia M, Czerniak B, Wistuba I, Mills G, Shaw K, Chen K, Sircar K. Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape. Clin Cancer Res 23(21):6686-6696, 2017. e-Pub 2017. PMID: 28710314.
26. Keskin SK, Msaouel P, Hess KR, Yu KJ, Matin SF, Sircar K, Tamboli P, Jonasch E, Wood CG, Karam JA, Tannir NM. Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras. J Urol 198(3):530-537, 2017. e-Pub 2017. PMID: 28411072.
27. Kalra S, Verma J, Atkinson BJ, Matin SF, Wood CG, Karam JA, Lin SH, Satcher RL, Tamboli P, Sircar K, Rao P, Corn PG, Tannir NM, Jonasch E. Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era. Clin Genitourin Cancer 15(3):363-370, 2017. e-Pub 2017. PMID: 28216278.
28. Reddy JP, Pettaway CA, Levy LB, Pagliaro LC, Tamboli P, Rao P, Jayaratna I, Hoffman KE. Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma. BJU Int 119(4):591-597, 2017. e-Pub 2017. PMID: 27753187.
29. de Velasco G, Culhane AC, Fay AP, Hakimi AA, Voss MH, Tannir NM, Tamboli P, Appleman LJ, Bellmunt J, Kimryn Rathmell W, Albiges L, Hsieh JJ, Heng DY, Signoretti S, Choueiri TK. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model. Oncologist 22(3):286-292, 2017. e-Pub 2017. PMID: 28220024.
30. Kawakami F, Rao P, Tamboli P, Wood CG, Karam JA. Study of the Kidney Tumor-Parenchymal Interface after Neoadjuvant Treatment with Axitinib for Locally Advanced Clear Cell Renal Cell Carcinoma: Matched Analysis from a Phase II Trial. J Urol 197(3 Pt 1):559-565, 2017. e-Pub 2017. PMID: 27678298.
31. Malouf GG, Su X, Zhang J, Creighton CJ, Ho TH, Lu Y, Raynal NJ, Karam JA, Tamboli P, Allanick F, Mouawad R, Spano JP, Khayat D, Wood CG, Jelinek J, Tannir NM. DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas. Clin Cancer Res 22(24):6236-6246, 2016. e-Pub 2016. PMID: 27256309.
32. de Velasco G, Miao D, Voss MH, Hakimi AA, Hsieh JJ, Tannir NM, Tamboli P, Appleman LJ, Rathmell WK, Van Allen EM, Choueiri TK. Tumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups. Cancer Immunol Res 4(10):820-822, 2016. e-Pub 2016. PMID: 27538576.
33. Malouf GG, Ali SM, Wang K, Balasubramanian S, Ross JS, Miller VA, Stephens PJ, Khayat D, Pal SK, Su X, Sircar K, Tamboli P, Jonasch E, Tannir NM, Wood CG, Karam JA. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations. Eur Urol 70(2):348-57, 2016. e-Pub 2016. PMID: 26895810.
34. Huang H, Tamboli P, Karam JA, Vikram R, Zhang M. Secondary malignancies diagnosed using kidney needle core biopsies: a clinical and pathological study of 75 cases. Hum Pathol 52:55-60, 2016. e-Pub 2016. PMID: 26980018.
35. Tannir NM, Jonasch E, Albiges L, Altinmakas E, Ng CS, Matin SF, Wang X, Qiao W, Dubauskas Lim Z, Tamboli P, Rao P, Sircar K, Karam JA, McDermott DF, Wood CG, Choueiri TK. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial. Eur Urol 69(5):866-74, 2016. e-Pub 2016. PMID: 26626617.
36. Zhou L, Liu XD, Sun M, Zhang X, German P, Bai S, Ding Z, Tannir N, Wood CG, Matin SF, Karam JA, Tamboli P, Sircar K, Rao P, Rankin EB, Laird DA, Hoang AG, Walker CL, Giaccia AJ, Jonasch E. Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene 35(21):2687-97, 2016. e-Pub 2016. PMID: 26364599.
37. Kalra S, Atkinson BJ, Matrana MR, Matin SF, Wood CG, Karam JA, Tamboli P, Sircar K, Rao P, Corn PG, Tannir NM, Jonasch E. Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases. BJU Int 117(5):761-5, 2016. e-Pub 2016. PMID: 26032863.
38. Zhou C, Urbauer DL, Fellman BM, Tamboli P, Zhang M, Matin SF, Wood CG, Karam JA. Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre. BJU Int 117(5):775-82, 2016. e-Pub 2016. PMID: 26053895.
39. Borregales LD, Kim DY, Staller AL, Qiao W, Thomas AZ, Adibi M, Tamboli P, Sircar K, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy. Urol Oncol 34(5):237.e19-26, 2016. e-Pub 2016. PMID: 26707613.
40. Thomas AZ, Adibi M, Slack RS, Borregales LD, Merrill MM, Tamboli P, Sircar K, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis. J Urol. e-Pub 2016. PMID: 27036304.
41. Ho TH, Park IY, Zhao H, Tong P, Champion MD, Yan H, Monzon FA, Hoang A, Tamboli P, Parker AS, Joseph RW, Qiao W, Dykema K, Tannir NM, Castle EP, Nunez-Nateras R, Teh BT, Wang J, Walker CL, Hung MC, Jonasch E. High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma. Oncogene 35(12):1565-74, 2016. e-Pub 2016. PMID: 26073078.
42. Chen F, Zhang Y, Senbabaoglu Y, Ciriello G, Yang L, Reznik E, Shuch B, Micevic G, De Velasco G, Shinbrot E, Noble MS, Lu Y, Covington KR, Xi L, Drummond JA, Muzny D, Kang H, Lee J, Tamboli P, Reuter V, Shelley CS, Kaipparettu BA, Bottaro DP, Godwin AK, Gibbs RA, Getz G, Kucherlapati R, Park PJ, Sander C, Henske EP, Zhou JH, Kwiatkowski DJ, Ho TH, Choueiri TK, Hsieh JJ, Akbani R, Mills GB, Hakimi AA, Wheeler DA, Creighton CJ. Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Rep 14(10):2476-89, 2016. e-Pub 2016. PMID: 26947078.
43. Research Network CGA, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AA, Shinbrot E, Sethi A, Brooks S, Rathmell WK, Brooks AN, Hoadley KA, Robertson AG, Brooks D, Bowlby R, Sadeghi S, Shen H, Weisenberger DJ, Bootwalla M, Baylin SB, Laird PW, Cherniack AD, Saksena G, Haake S, Li J, Liang H, Lu Y, Mills GB, Akbani R, Leiserson MD, Raphael BJ, Anur P, Bottaro D, Albiges L, Barnabas N, Choueiri TK, Czerniak B, Godwin AK, Hakimi AA, Ho TH, Hsieh J, Ittmann M, Kim WY, Krishnan B, Merino MJ, Mills Shaw KR, Reuter VE, Reznik E, Shelley CS, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Tickoo S, Burnett K, Crain D, Gardner J, Lau K, Mallery D, Morris S, Paulauskis JD, Penny RJ, Shelton C, Shelton WT, Sherman M, Thompson E, Yena P, Avedon MT, Bowen J, Gastier-Foster JM, Gerken M, Leraas KM, Lichtenberg TM, Ramirez NC, Santos T, Wise L, Zmuda E, Demchok JA, Felau I, Hutter CM, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang J, Ayala B, Baboud J, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan Y, Wu Y, Ally A, Balasundaram M, Balu S, Beroukhim R, Bodenheimer T, Buhay C, Butterfield YS, Carlsen R, Carter SL, Chao H, Chuah E, Clarke A, Covington KR, Dahdouli M, Dewal N, Dhalla N, Doddapaneni HV, Drummond JA, Gabriel SB, Gibbs RA, Guin R, Hale W, Hawes A, Hayes DN, Holt RA, Hoyle AP, Jefferys SR, Jones SJ, Jones CD, Kalra D, Kovar C, Lewis L, Li J, Ma Y, Marra MA, Mayo M, Meng S, Meyerson M, Mieczkowski PA, Moore RA, Morton D, Mose LE, Mungall AJ, Muzny D, Parker JS, Perou CM, Roach J, Schein JE, Schumacher SE, Shi Y, Simons JV, Sipahimalani P, Skelly T, Soloway MG, Sougnez C, Tam A, Tan D, Thiessen N, Veluvolu U, Wang M, Wilkerson MD, Wong T, Wu J, Xi L, Zhou J, Bedford J, Chen F, Fu Y, Gerstein M, Haussler D, Kasaian K, Lai P, Ling S, Radenbaugh A, Van Den Berg D, Weinstein JN, Zhu J, Albert M, Alexopoulou I, Andersen JJ, Auman JT, Bartle. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med 374(2):135-45, 2016. e-Pub 2016. PMID: 26536169.
44. Ghosh P, Tamboli P, Vikram R, Rao A. Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features. J Med Imaging (Bellingham) 2(4):041009, 2015. e-Pub 2015. PMID: 26839909.
45. Sircar K, Yoo SY, Majewski T, Wani K, Patel LR, Voicu H, Torres-Garcia W, Verhaak RG, Tannir N, Karam JA, Jonasch E, Wood CG, Tamboli P, Baggerly KA, Aldape KD, Czerniak B. Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non-sarcomatoid renal carcinomas. J Pathol Clin Res 1(4):212-24, 2015. e-Pub 2015. PMID: 27499906.
46. Adibi M, Thomas AZ, Borregales LD, Merrill MM, Slack RS, Chen HC, Sircar K, Murugan P, Tamboli P, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation. Urol Oncol 33(10):427.e17-23, 2015. e-Pub 2015. PMID: 26004164.
47. Singh RR, Murugan P, Patel LR, Voicu H, Yoo SY, Majewski T, Mehrotra M, Wani K, Tannir N, Karam JA, Jonasch E, Wood CG, Creighton CJ, Medeiros LJ, Broaddus RR, Tamboli P, Baggerly KA, Aldape KD, Czerniak B, Luthra R, Sircar K. Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy. Mod Pathol 28(9):1225-35, 2015. e-Pub 2015. PMID: 26111976.
48. Liu XD, Hoang A, Zhou L, Kalra S, Yetil A, Sun M, Ding Z, Zhang X, Bai S, German P, Tamboli P, Rao P, Karam JA, Wood C, Matin S, Zurita A, Bex A, Griffioen AW, Gao J, Sharma P, Tannir N, Sircar K, Jonasch E. Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma. Cancer Immunol Res 3(9):1017-29, 2015. e-Pub 2015. PMID: 26014097.
49. Thomas AZ, Adibi M, Borregales LD, Hoang LN, Tamboli P, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy. J Urol 194(2):316-22, 2015. e-Pub 2015. PMID: 25758610.
50. Aron M, Chang E, Herrera L, Hes O, Hirsch MS, Comperat E, Camparo P, Rao P, Picken M, Michal M, Montironi R, Tamboli P, Monzon F, Amin MB. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor. Am J Surg Pathol 39(7):873-88, 2015. e-Pub 2015. PMID: 25970682.
51. Kenney PA, Vikram R, Prasad SR, Tamboli P, Matin SF, Wood CG, Karam JA. Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney: A Detailed Study of Radiologic, Pathologic and Clinical Outcomes. BJU Int 116(1):85-92, 2015. e-Pub 2015. PMID: 25395040.
52. Merrill MM, Wood CG, Tannir NM, Slack RS, Babaian KN, Jonasch E, Pagliaro LC, Compton Z, Tamboli P, Sircar K, Pisters LL, Matin SF, Karam JA. Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent. Urol Oncol 33(4):166.e21-9, 2015. e-Pub 2015. PMID: 25700975.
53. Babaian KN, Kim DY, Kenney PA, Wood CG, Wong J, Sanchez C, Fang JE, Gerber JA, Didic A, Wahab A, Golla V, Torres C, Tamboli P, Qiao W, Matin SF, Wood CG, Karam JA. Preoperative Predictors of Pathological Lymph Node Metastasis in Patients with Renal Cell Carcinoma Undergoing Retroperitoneal Lymph Node Dissection. J Urol 193(4):1101-7, 2015. e-Pub 2015. PMID: 25390078.
54. Ho TH, Liu XD, Huang Y, Warneke CL, Johnson MM, Hoang A, Tamboli P, Wang F, Jonasch E. The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma. BMC Cancer 15:304, 2015. e-Pub 2015. PMID: 25900027.
55. Rao P, Tamboli P, Fillman EP, Meis JM. Primary intra-renal desmoplastic small round cell tumor: expanding the histologic spectrum, with special emphasis on the differential diagnostic considerations. Pathol Res Pract 210(12):1130-3, 2014. e-Pub 2014. PMID: 24953786.
56. Rioux-Leclercq N, Ferran A, Mahul A, Argani P, Billis A, Bonsib S, Cheng L, Cheville J, Eble J, Egevad L, Epstein J, Grignon D, Hes O, Humphrey P, Magi-Galluzzi C, Martignoni G, McKenney J, Merino M, Moch H, Montironi R, Netto G, Reuter V, Samaratunga H, Shen S, Srigley J, Tamboli P, Tan PH, Tickoo S, Trpkov K, Zhou M, Delahunt B, Comperat E. [Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations]. Ann Pathol 34(6):448-61, 2014. e-Pub 2014. PMID: 25499860.
57. Abel EJ, Carrasco A, Karam J, Tamboli P, Delacroix S, Vaporciyan AA, Wood CG. Positive vascular wall margins have minimal impact on cancer outcomes in non-metastatic RCC patients with tumor thrombus. BJU Int 114(5):667-73, 2014. e-Pub 2014. PMID: 24128265.
58. Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M, Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK, Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA, Research Network CGA, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D, Wheeler DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJ. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell 26(3):319-30, 2014. e-Pub 2014. PMID: 25155756.
59. Rao P, Monzon F, Jonasch E, Matin SF, Tamboli P. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases. Hum Pathol 45(9):1966-72, 2014. e-Pub 2014. PMID: 25081542.
60. Amin MB, Smith SC, Eble JN, Rao P, Choi WW, Tamboli P, Young RH. Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification. Am J Surg Pathol 38(8):1033-45, 2014. e-Pub 2014. PMID: 25025366.
61. Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Kattan MW, Hakimi AA, Hsieh JJ, Choueiri TK, Tamboli P, Maranchie JK, Hinds P, Miller CR, Nielsen ME, Rathmell WK. ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 66(1):77-84, 2014. e-Pub 2014. PMID: 24613583.
62. Burch-Smith R, Tannir NM, Resetkova E, Tamboli P, Rao P. Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow-up. Chin J Cancer 33(7):351-5, 2014. e-Pub 2014. PMID: 24589208.
63. Babaian KN, Merrill MM, Matin S, Tamboli P, Tannir NM, Jonasch E, Wood CG, Karam JA. Partial nephrectomy in the setting of metastatic renal cell carcinoma. J Urol 192(1):36-42, 2014. e-Pub 2014. PMID: 24518767.
64. Karam JA, Devine CE, Urbauer DL, Lozano M, Maity T, Ahrar K, Tamboli P, Tannir NM, Wood CG. Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma. Eur Urol. e-Pub 2014. PMID: 24560330.
65. Begg CB, Seshan VE, Zabor EC, Furberg H, Arora A, Shen R, Maranchie JK, Nielsen ME, Rathmell WK, Signoretti S, Tamboli P, Karam JA, Choueiri TK, Hakimi AA, Hsieh JJ. Genomic investigation of etiologic heterogeneity: methodologic challenges. BMC Med Res Methodol 14:138, 2014. e-Pub 2014. PMID: 25532962.
66. Rasmussen NR, Debebe Z, Wright TM, Brooks SA, Sendor AB, Brannon AR, Hakimi AA, Hsieh JJ, Choueiri TK, Tamboli P, Maranchie JK, Hinds P, Wallen EM, Simpson C, Norris JL, Janzen WP, Rathmell WK. Expression of ror2 mediates invasive phenotypes in renal cell carcinoma. PLoS One 9(12):e116101, 2014. e-Pub 2014. PMID: 25542006.
67. Satcher RL, Pan T, Cheng CJ, Lee YC, Lin SC, Yu G, Li X, Hoang AG, Tamboli P, Jonasch E, Gallick GE, Lin SH. Cadherin-11 in renal cell carcinoma bone metastasis. PLoS One 9(2):e89880, 2014. e-Pub 2014. PMID: 24587095.
68. Lewis RE, Cahyame-Zuniga L, Leventakos K, Chamilos G, Ben-Ami R, Tamboli P, Tarrand J, Bodey GP, Luna M, Kontoyiannis DP. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses 56(6):638-45, 2013. e-Pub 2013. PMID: 23551865.
69. Richey SL, Tamboli P, Ng CS, Lin E, Lim ZD, Araujo JC, Jonasch E, Sharma P, Pagliaro LC, Tannir NM. Phase II Trial of Pemetrexed Plus Gemcitabine in Patients With Locally Advanced and Metastatic Nonclear Cell Renal Cell Carcinoma. Am J Clin Oncol 36(5):450-4, 2013. e-Pub 2013. PMID: 22706175.
70. Trpkov K, Grignon DJ, Bonsib SM, Amin MB, Billis A, Lopez-Beltran A, Samaratunga H, Tamboli P, Delahunt B, Egevad L, Montironi R, Srigley JR, Tumor Panel MOTIR. Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations. Am J Surg Pathol 37(10):1505-17, 2013. e-Pub 2013. PMID: 24025521.
71. Malouf GG, Monzon FA, Couturier J, Molinié V, Escudier B, Camparo P, Su X, Yao H, Tamboli P, Lopez-Terrada D, Picken M, Garcia M, Multani AS, Pathak S, Wood CG, Tannir NM. Genomic heterogeneity of translocation renal cell carcinoma. Clin Cancer Res 19(17):4673-84, 2013. e-Pub 2013. PMID: 23817689.
72. Research Network TCGA. Comprehensivemolecular characterization of clear cell renal cell carcinoma. Nature 499(7456):43-49, 2013. e-Pub 2013.
73. Zhao Q, Caballero OL, Davis ID, Jonasch E, Tamboli P, Yung WK, Weinstein JN, research network KSFT, Strausberg RL, Yao J. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas. Clin Cancer Res 19(9):2460-72, 2013. e-Pub 2013. PMID: 23444225.
74. Margulis V, Shariat SF, Rapoport Y, Rink M, Sjoberg DD, Tannir NM, Abel EJ, Culp SH, Tamboli P, Wood CG. Development of Accurate Models for Individualized Prediction of Survival After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma. Eur Urol 63(5):947-52, 2013. e-Pub 2013. PMID: 23273681.
75. Tannir NM, Plimack E, Ng C, Tamboli P, Bekele NB, Xiao L, Smith L, Lim Z, Pagliaro L, Araujo J, Aparicio A, Matin S, Wood CG, Jonasch E. A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma. Eur Urol 62(6):1013-9, 2012. e-Pub 2012. PMID: 22771265.
76. Abel EJ, Carrasco A, Culp SH, Matin SF, Tamboli P, Tannir NM, Wood CG. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases. BJU Int 110(11):1742-6, 2012. e-Pub 2012. PMID: 22503066.
77. Guo H, Liu W, Ju Z, Tamboli P, Jonasch E, Mills GB, Lu Y, Hennessy B, Tsavachidou D. An efficient procedure for protein extraction from formalin-fixed, paraffin-embedded tissues for reverse phase protein arrays. Proteome Sci 10(1):56. e-Pub 2012. PMID: 23006314.
78. Rao P, Tannir NM, Tamboli P. Expression of OCT3/4 in renal medullary carcinoma represents a potential diagnostic pitfall. Am J Surg Pathol 36(4):583-8, 2012. e-Pub 2012. PMID: 22301499.
79. Hildebrandt MA, Tan W, Tamboli P, Huang M, Ye Y, Lin J, Lee JS, Wood CG, Wu X. Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients. Carcinogenesis 33(4):799-803, 2012. e-Pub 2012. PMID: 22266464.
80. Cohen L, Cole SW, Sood AK, Prinsloo S, Kirschbaum C, Arevalo JM, Jennings NB, Scott S, Vence L, Wei Q, Kentor D, Radvanyi L, Tannir N, Jonasch E, Tamboli P, Pisters L. Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PLoS One 7(8):e42324, 2012. e-Pub 2012. PMID: 22870317.
81. Abel EJ, Culp SH, Tannir NM, Tamboli P, Matin SF, Wood CG. Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib. Eur Urol 60(6):1273-9, 2011. e-Pub 2011. PMID: 21784574.
82. Chapin BF, Delacroix SE, Culp SH, Nogueras Gonzalez GM, Tannir NM, Jonasch E, Tamboli P, Wood CG. Safety of Presurgical Targeted Therapy in the Setting of Metastatic Renal Cell Carcinoma. Eur Urol 60(5):964-71, 2011. e-Pub 2011. PMID: 21621907.
83. Si Q, Dancer J, Stanton ML, Tamboli P, Ro JY, Czerniak BA, Shen SS, Guo CC. Small cell carcinoma of the kidney: a clinicopathologic study of 14 cases. Hum Pathol 42(11):1792-8, 2011. e-Pub 2011. PMID: 21733553.
84. Tamboli DA, Harris MA, Hogg JP, Realini T, Sivak-Callcott JA. Computed tomography dimensions of the lacrimal gland in normal Caucasian orbits. Ophthal Plast Reconstr Surg 27(6):453-6, 2011. e-Pub 2011. PMID: 21659915.
85. Tan W, Hildebrandt MA, Pu X, Huang M, Lin J, Matin SF, Tamboli P, Wood CG, Wu X. Role of Inflammatory Related Gene Expression in Clear Cell Renal Cell Carcinoma Development and Clinical Outcomes. J Urol 186(5):2071-7, 2011. e-Pub 2011. PMID: 21944129.
86. Delacroix SE, Chapin BF, Chen JJ, Nogueras-Gonzalez GM, Tamboli P, Matin SF, Wood CG. Can a Durable Disease-Free Survival be Achieved With Surgical Resection in Patients With Pathological Node Positive Renal Cell Carcinoma?. J Urol 186(4):1236-41, 2011. e-Pub 2011. PMID: 21849197.
87. Ueda Y, Hajri T, Peng D, Marks-Shulman PA, Tamboli RA, Shukrallah B, Saliba J, Jabbour K, El-Rifai W, Abumrad NA, Abumrad NN. Reduction of 8-iso-prostaglandin F2α in the first week after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) 19(8):1663-8, 2011. e-Pub 2011. PMID: 21475145.
88. Jadhav M, Kalme S, Tamboli D, Govindwar S. Rhamnolipid from Pseudomonas desmolyticum NCIM-2112 and its role in the degradation of Brown 3REL. J Basic Microbiol 51(4):385-96, 2011. e-Pub 2011. PMID: 21656804.
89. Tamboli IY, Tien NT, Walter J. Sphingolipid storage impairs autophagic clearance of Alzheimer-associated proteins. Autophagy 7(6):645-6, 2011. e-Pub 2011. PMID: 21460623.
90. Richey SL, Culp SH, Jonasch E, Corn PG, Pagliaro LC, Tamboli P, Patel KK, Matin SF, Wood CG, Tannir NM. Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy. Ann Oncol 22(5):1048-53, 2011. e-Pub 2011. PMID: 21115604.
91. Hansen EN, Tamboli RA, Isbell JM, Saliba J, Dunn JP, Marks-Shulman PA, Abumrad NN. Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol 300(5):G795-802, 2011. e-Pub 2011. PMID: 21372167.
92. Kamal A, Suresh P, Mallareddy A, Kumar BA, Reddy PV, Raju P, Tamboli JR, Shaik TB, Jain N, Kalivendi SV. Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents. Bioorg Med Chem 19(7):2349-58, 2011. e-Pub 2011. PMID: 21402478.
93. Karam JA, Zhang XY, Tamboli P, Margulis V, Wang H, Abel EJ, Culp SH, Wood CG. Development and Characterization of Clinically Relevant Tumor Models From Patients With Renal Cell Carcinoma. Eur Urol 59(4):619-28, 2011. e-Pub 2011. PMID: 21167632.
94. Tamboli V, Defant A, Mancini I, Tosi P. A study of resveratrol-copper complexes by electrospray ionization mass spectrometry and density functional theory calculations. Rapid Commun Mass Spectrom 25(4):526-32, 2011. e-Pub 2011. PMID: 21259361.
95. Tamboli IY, Hampel H, Tien NT, Tolksdorf K, Breiden B, Mathews PM, Saftig P, Sandhoff K, Walter J. Sphingolipid storage affects autophagic metabolism of the amyloid precursor protein and promotes Abeta generation. J Neurosci 31(5):1837-49, 2011. e-Pub 2011. PMID: 21289194.
96. Ahiwale S, Tamboli N, Thorat K, Kulkarni R, Ackermann H, Kapadnis B. In vitro management of hospital Pseudomonas aeruginosa biofilm using indigenous T7-like lytic phage. Curr Microbiol 62(2):335-40, 2011. e-Pub 2011. PMID: 20711581.
97. Khandare RV, Kabra AN, Tamboli DP, Govindwar SP. The role of Aster amellus Linn. in the degradation of a sulfonated azo dye Remazol Red: a phytoremediation strategy. Chemosphere 82(8):1147-54, 2011. e-Pub 2011. PMID: 21239039.
98. Abou Youssif T, Fahmy MA, Koumakpayi IH, Ayala F, Al Marzooqi S, Chen G, Tamboli P, Squire J, Tanguay S, Sircar K. The mammalian target of rapamycin pathway is widely activated without PTEN deletion in renal cell carcinoma metastases. Cancer 117(2):290-300, 2011. e-Pub 2011. PMID: 20830770.
99. Abel EJ, Culp SH, Tannir NM, Matin SF, Tamboli P, Jonasch E, Wood CG. Primary Tumor Response to Targeted Agents in Patients with Metastatic Renal Cell Carcinoma. Eur Urol 59(1):10-5, 2011. e-Pub 2011. PMID: 20952123.
100. Dhillon J, Tannir NM, Matin SF, Tamboli P, Czerniak BA, Guo CC. Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol 42(1):146-50, 2011. e-Pub 2011. PMID: 20971497.
101. Choueiri TK, Lim ZD, Hirsch MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM. Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma. Cancer 116(22):5219-25, 2010. e-Pub 2010. PMID: 20665500.
102. Abel EJ, Culp SH, Meissner M, Matin SF, Tamboli P, Wood CG. Identifying the risk of disease progression after surgery for localized renal cell carcinoma. BJU Int 106(9):1277-83, 2010. e-Pub 2010. PMID: 20394619.
103. Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG. Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment. J Urol 184(5):1877-81, 2010. e-Pub 2010. PMID: 20850148.
104. Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W, Tamboli P, Wood CG, Wu X. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 29(42):5724-8, 2010. e-Pub 2010. PMID: 20676129.
105. Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 31(10):1805-12, 2010. e-Pub 2010. PMID: 20732906.
106. Katabathina VS, Vikram R, Nagar AM, Tamboli P, Menias CO, Prasad SR. Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation. Radiographics 30(6):1525-40, 2010. e-Pub 2010. PMID: 21071373.
107. Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, Iczkowski KA, Lopez-Beltran A, Oliva E, Paner GP, Reuter VE, Ro JY, Shah RB, Shen SS, Tamboli P, McKenney JK. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol 34(9):1367-76, 2010. e-Pub 2010. PMID: 20717002.
108. Chaux A, Lezcano C, Cubilla AL, Tamboli P, Ro J, Ayala A. Comparison of Subtypes of Penile Squamous Cell Carcinoma From High and Low Incidence Geographical Regions. Int J Surg Pathol 18(4):268-77, 2010. e-Pub 2010. PMID: 19578046.
109. Tsavachidou-Fenner D, Tannir N, Tamboli P, Liu W, Petillo D, Teh B, Mills GB, Jonasch E. Gene and protein expression markers of response to combined antiangiogenic and epidermal growth factor targeted therapy in renal cell carcinoma. Ann Oncol 21(8):1599-606, 2010. e-Pub 2010. PMID: 20089566.
110. Culp SH, Tannir NM, Abel EJ, Margulis V, Tamboli P, Matin SF, Wood CG. Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?. Cancer 116(14):3378-88, 2010. e-Pub 2010. PMID: 20564061.
111. Fang X, Gupta N, Shen SS, Tamboli P, Charnsangavej C, Rashid A, Wang H. Intraluminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp. Arch Pathol Lab Med 134(7):1003-9, 2010. e-Pub 2010. PMID: 20586628.
112. Contreras AL, Punar M, Tamboli P, Tu SM, Pisters L, Moran C, Czerniak BA, Guo CC. Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases. Hum Pathol 41(6):832-7, 2010. e-Pub 2010. PMID: 20153508.
113. Nicolas MM, Tamboli P, Gomez JA, Czerniak BA. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases. Hum Pathol 41(5):663-71, 2010. e-Pub 2010. PMID: 20004935.
114. Jonasch E, Corn P, Pagliaro LC, Warneke CL, Johnson MM, Tamboli P, Ng C, Aparicio A, Ashe RG, Wright JJ, Tannir NM. Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis. Cancer 116(1):57-65, 2010. e-Pub 2010. PMID: 19862815.
115. Svatek RS, Munsell M, Kincaid JM, Hegarty P, Slaton JW, Busby JE, Gaston KE, Spiess PE, Pagliaro LC, Tamboli P, Pettaway CA. Association between lymph node density and disease specific survival in patients with penile cancer. J Urol 182(6):2721-7, 2009. e-Pub 2009. PMID: 19837433.
116. Chen M, Ye Y, Yang H, Tamboli P, Matin S, Tannir NM, Wood CG, Gu J, Wu X. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int J Cancer 125(10):2342-8, 2009. e-Pub 2009. PMID: 19521957.
117. Guo CC, Gomez E, Tamboli P, Bondaruk JE, Kamat A, Bassett R, Dinney CP, Czerniak BA. Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases. Hum Pathol 40(10):1448-52, 2009. e-Pub 2009. PMID: 19454359.
118. Jonasch E, Wood CG, Matin SF, Tu SM, Pagliaro LC, Corn PG, Aparicio A, Tamboli P, Millikan RE, Wang X, Araujo JC, Arap W, Tannir N. Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. J Clin Oncol 27(25):4076-81, 2009. e-Pub 2009. PMID: 19636008.
119. Guo CC, Punar M, Contreras AL, Tu SM, Pisters L, Tamboli P, Czerniak B. Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases. Am J Surg Pathol 33(8):1173-8, 2009. e-Pub 2009. PMID: 19561445.
120. Margulis V, McDonald M, Tamboli P, Swanson DA, Wood CG. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. J Urol 181(5):2044-51, 2009. e-Pub 2009. PMID: 19286220.
121. Clague J, Lin J, Cassidy A, Matin S, Tannir NM, Tamboli P, Wood CG, Wu X. Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis. Cancer Epidemiol Biomarkers Prev 18(3):801-7, 2009. e-Pub 2009. PMID: 19240244.
122. Nigwekar P, Tamboli P, Amin MB, Osunkoya AO, Ben-Dor D, Amin MB. Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases. Am J Surg Pathol 33(3):417-24, 2009. e-Pub 2009. PMID: 19011563.
123. Margulis V, Matin SF, Tannir N, Tamboli P, Shen Y, Lozano M, Swanson DA, Jonasch E, Wood CG. Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma. Urology 73(2):337-41, 2009. e-Pub 2009. PMID: 18950837.
124. Kim J, Jonasch E, Alexander A, Short JD, Cai S, Wen S, Tsavachidou D, Tamboli P, Czerniak BA, Do KA, Wu KJ, Marlow LA, Wood CG, Copland JA, Walker CL. Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin Cancer Res 15(1):81-90, 2009. e-Pub 2009. PMID: 19118035.
125. Guo CC, Tamboli P, Czerniak B. Micropapillary variant of urothelial carcinoma in the upper urinary tract: a clinicopathologic study of 11 cases. Arch Pathol Lab Med 133(1):62-6, 2009. e-Pub 2009. PMID: 19123738.
126. Bilen MA, Waguespack SG, Tannir NM, Pravinkumar SE, Tamboli P, Tu SM. Multisystem crisis in a patient with presumptive renal cell carcinoma. Clin Genitourin Cancer 6(2):128-30, 2008. e-Pub 2008. PMID: 18824438.
127. Margulis V, Matin SF, Tannir N, Tamboli P, Swanson DA, Jonasch E, Wood CG. Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma. J Urol 180(1):94-8, 2008. e-Pub 2008. PMID: 18485389.
128. Ricketts R, Tamboli P, Czerniak B, Guo CC. Tumor-to-tumor metastasis: report of 2 cases of metastatic carcinoma to angiomyolipoma of the kidney. Arch Pathol Lab Med 132(6):1016-20, 2008. e-Pub 2008. PMID: 18517262.
129. Jonasch E, Wood C, Tamboli P, Pagliaro LC, Tu SM, Kim J, Srivastava P, Perez C, Isakov L, Tannir N. Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings. Br J Cancer 98(8):1336-41, 2008. e-Pub 2008. PMID: 18362942.
130. Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CG. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer 112(7):1480-8, 2008. e-Pub 2008. PMID: 18240184.
131. Booth J, Matin SF, Ahrar K, Tamboli P, Wood CG. Contemporary strategies for treating nonhereditary synchronous bilateral renal tumors and the impact of minimally invasive, nephron-sparing techniques. Urol Oncol 26(1):37-42, 2008. e-Pub 2008. PMID: 18190828.
132. Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. BJU Int 100(6):1235-9, 2007. e-Pub 2007. PMID: 17979923.
133. Vakar-Lopez F, Shen SS, Zhang S, Tamboli P, Ayala AG, Ro JY. Muscularis mucosae of the urinary bladder revisited with emphasis on its hyperplastic patterns: a study of a large series of cystectomy specimens. Ann Diagn Pathol 11(6):395-401, 2007. e-Pub 2007. PMID: 18022122.
134. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. J Urol 178(5):1878-82, 2007. e-Pub 2007. PMID: 17868733.
135. Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, Matin S, Swanson DA, Wood CG. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology. J Urol 178(5):1896-900, 2007. e-Pub 2007. PMID: 17868729.
136. Javadi S, Matin SF, Tamboli P, Ahrar K. Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J Vasc Interv Radiol 18(9):1186-91, 2007. e-Pub 2007. PMID: 17804784.
137. Kamat AM, Dinney CP, Gee JR, Grossman HB, Siefker-Radtke AO, Tamboli P, Detry MA, Robinson TL, Pisters LL. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer 110(1):62-7, 2007. e-Pub 2007. PMID: 17542024.
138. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system. Cancer 109(12):2439-44, 2007. e-Pub 2007. PMID: 17487856.
139. Spiess PE, Izawa JI, Bassett R, Kedar D, Busby JE, Wong F, Eddings T, Tamboli P, Pettaway CA. Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation. J Urol 177(6):2157-61, 2007. e-Pub 2007. PMID: 17509308.
140. Margulis V, Sánchez-Ortiz RF, Tamboli P, Cohen DD, Swanson DA, Wood CG. Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management. Cancer 109(10):2025-30, 2007. e-Pub 2007. PMID: 17420980.
141. Spiess PE, Tuziak T, Tibbs RF, Bassett R, Tamboli P, Brown GA, Grossman HB, Ayala AG, Czerniak B. Pseudosarcomatous and sarcomatous proliferations of the bladder. Hum Pathol 38(5):753-61, 2007. e-Pub 2007. PMID: 17306332.
142. Kassouf W, Sanchez-Ortiz R, Tamboli P, Jonasch E, Merchant MM, Spiess PE, Wood CG. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience. Urology 69(5):835-8, 2007. e-Pub 2007. PMID: 17482917.
143. Kader AK, Tamboli P, Luongo T, Matin SF, Bell K, Jonasch E, Swanson DA, Wood CG. Cytoreductive nephrectomy in the elderly patient: the m. D. Anderson cancer center experience. J Urol 177(3):855-61, 2007. e-Pub 2007. PMID: 17296358.
144. Shen SS, Ro JY, Tamboli P, Truong LD, Zhai Q, Jung SJ, Tibbs RG, Ordonez NG, Ayala AG. Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features. Ann Diagn Pathol 11(1):13-21, 2007. e-Pub 2007. PMID: 17240302.
145. Busby JE, Brown GA, Tamboli P, Kamat AM, Dinney CP, Grossman HB, Matin SF. Upper urinary tract tumors with nontransitional histology: a single-center experience. Urology 67(3):518-23, 2006. e-Pub 2006. PMID: 16527570.
146. Johnson FM, Krug LM, Tran HT, Shoaf S, Prieto VG, Tamboli P, Peeples B, Patel J, Glisson BS. Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma. Cancer 106(2):366-74, 2006. e-Pub 2006. PMID: 16342249.
147. Skinnider BF, Folpe AL, Hennigar RA, Lim SD, Cohen C, Tamboli P, Young A, de Peralta-Venturina M, Amin MB. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol 29(6):747-54, 2005. e-Pub 2005. PMID: 15897741.
148. Sánchez-Ortiz R, Huang SF, Tamboli P, Prieto VG, Hester G, Pettaway CA. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience. J Urol 173(6):1958-65, 2005. e-Pub 2005. PMID: 15879790.
149. Abrahams NA, MacLennan GT, Khoury JD, Ormsby AH, Tamboli P, Doglioni C, Schumacher B, Tickoo SK. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 45(6):593-602, 2004. e-Pub 2004. PMID: 15569050.
150. Kamat AM, Plager C, Tamboli P, Tran N, Pettaway CA. Metastatic epithelioid hemangioendothelioma of the penis managed with surgery and interferon-alpha. J Urol 171(5):1886-7, 2004. e-Pub 2004. PMID: 15076299.
151. Naya Y, Ayala AG, Tamboli P, Babaian RJ. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?. Urology 63(3):503-8, 2004. e-Pub 2004. PMID: 15028446.
152. Copland JA, Luxon BA, Ajani L, Maity T, Campagnaro E, Guo H, LeGrand SN, Tamboli P, Wood CG. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression. Oncogene 22(39):8053-62, 2003. e-Pub 2003. PMID: 12970754.
153. Toprani TH, Tamboli P, Amin MB, Ordoñez NG, Ayala AG, Ro JY. Thymic carcinoma with rhabdoid features. Ann Diagn Pathol 7(2):106-11, 2003. e-Pub 2003. PMID: 12715336.
154. Ramalingam P, Middleton LP, Tamboli P, Troncoso P, Silva EG, Ayala AG. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features. Ann Diagn Pathol 7(2):112-9, 2003. e-Pub 2003. PMID: 12715337.
155. Ayala AG, Naya Y, Tamboli P, Babaian RJ. High-Grade Prostatic Intraepithelial Neoplasia (PIN) and Invasive Adenocarcinoma: Case Report and Preliminary Study of 103 Patients with High-Grade PIN. Pathol Case Rev 8:61-67, 2003. e-Pub 2003.
156. Che M, Tamboli P, Ro JY, Park DS, Ro JS, Amato RJ, Ayala AG. Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center. Cancer 95(6):1228-33, 2002. e-Pub 2002. PMID: 12216089.
157. Tamboli P, Mohsin SK, Hailemariam S, Amin MB. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. Arch Pathol Lab Med 126(9):1057-63, 2002. e-Pub 2002. PMID: 12204054.
158. Varma M, Morgan M, Jasani B, Tamboli P, Amin MB. Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: Implications for diagnostic prostatic pathology. Am J Clin Pathol 118(2):202-7, 2002. e-Pub 2002. PMID: 12162678.
159. Inoue K, Kamada M, Slaton JW, Fukata S, Yoshikawa C, Tamboli P, Dinney CP, Shuin T. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter. Clin Cancer Res 8(6):1863-70, 2002. e-Pub 2002. PMID: 12060629.
160. Varma M, Lee MW, Tamboli P, Zarbo RJ, Jimenez RE, Salles PG, Amin MB. Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice. Arch Pathol Lab Med 126(5):554-61, 2002. e-Pub 2002. PMID: 11958660.
161. Copeland JN, Amin MB, Humphrey PA, Tamboli P, Ro JY, Gal AA. The morphologic spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms. Am J Clin Pathol 117(4):552-7, 2002. e-Pub 2002. PMID: 11939729.
162. Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A, Menon M. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26(3):281-91, 2002. e-Pub 2002. PMID: 11859199.
163. Amin MB, Tamboli P, Merchant SH, Ordóñez NG, Ro J, Ayala AG, Ro JY. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 26(3):358-64, 2002. e-Pub 2002. PMID: 11859208.
164. Merchant SH, Amin MB, Tamboli P, Ro J, Ordóñez NG, Ayala AG, Czerniak BA, Ro JY. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Am J Surg Pathol 82(12):325A, 2002. e-Pub 2002. PMID: 11717541.
165. Slaton JW, Morgenstern N, Levy DA, Santos MW, Tamboli P, Ro JY, Ayala AG, Pettaway CA. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol 165(4):1138-42, 2001. e-Pub 2001. PMID: 11257655.
166. de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, Javidan J, Stricker H, Ro JY, Amin MB. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 25(3):275-84, 2001. e-Pub 2001. PMID: 11224597.
167. Jimenez RE, Eble JN, Reuter VE, Epstein JI, Folpe AL, de Peralta-Venturina M, Tamboli P, Ansell ID, Grignon DJ, Young RH, Amin MB. Concurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases. Mod Pathol 14(3):157-63, 2001. e-Pub 2001. PMID: 11266520.
168. Philip AT, Amin MB, Tamboli P, Lee TJ, Hill CE, Ro JY. Intravesical adipose tissue: a quantitative study of its presence and location with implications for therapy and prognosis. Am J Surg Pathol 24(9):1286-90, 2000. e-Pub 2000. PMID: 10976704.
169. Javidan J, Stricker HJ, Tamboli P, Amin MB, Peabody JO, Deshpande A, Menon M, Amin MB. Prognostic significance of the 1997 TNM classification of renal cell carcinoma. J Urol 162(4):1277-81, 1999. e-Pub 1999. PMID: 10492179.
170. Amin MB, Tamboli P, Varma M, Srigley JR. Postatrophic hyperplasia of the prostate gland: a detailed analysis of its morphology in needle biopsy specimens. Am J Surg Pathol 23(8):925-31, 1999. e-Pub 1999. PMID: 10435562.
171. Hailemariam S, Gaspert A, Komminoth P, Tamboli P, Amin M. Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder. Mod Pathol 11(10):1016-20, 1998. e-Pub 1998. PMID: 9796733.
172. Tamboli P, Amin MB, Xu HJ, Linden MD. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate. Mod Pathol 11(3):247-52, 1998. e-Pub 1998. PMID: 9521470.
173. Tamboli P, Amin MB, Schultz DS, Linden MD, Kubus J. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Mod Pathol 9(10):1015-9, 1996. e-Pub 1996. PMID: 8902840.
174. Stricker HJ, Jay JK, Linden MD, Tamboli P, Amin MB. Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53. Urology 47(3):366-9, 1996. e-Pub 1996. PMID: 8633403.

Invited Articles

1. Sircar K, Rao P, Jonasch E, Monzon FA, Tamboli P. Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features. Chin J Cancer 32(6):303-11, 2013. e-Pub 2013. PMID: 23237216.
2. Abrahams NA, Tamboli P. Oncocytic renal neoplasms: diagnostic considerations. Clin Lab Med 25(2):317-39, vi, 2005. e-Pub 2005. PMID: 15848739.
3. Tamboli P, Ro JY. Villous adenoma of urinary tract: a common tumor in an uncommon location. Adv Anat Pathol 7(2):79-84, 2000. e-Pub 2000. PMID: 10721414.
4. Tamboli P, Ro JY, Amin MB, Ligato S, Ayala AG. Benign tumors and tumor-like lesions of the adult kidney. Part II: Benign mesenchymal and mixed neoplasms, and tumor-like lesions. Adv Anat Pathol 7(1):47-66, 2000. e-Pub 2000. PMID: 10640201.
5. Ligato S, Ro JY, Tamboli P, Amin MB, Ayala AG. Benign tumors and tumor-like lesions of the adult kidney. Part I: Benign renal epithelial neoplasms. Adv Anat Pathol 6(1):1-11, 1999. e-Pub 1999. PMID: 10197234.

Review Articles

1. Hwang, MJ, Brennan, P, Monge, BM, Alkamachi, B, Rohra, P, Peshoff, MM, Sharma, P, Sircar, K, Tamboli, P, Rao, P. Best practices and recommendations for grossing and reporting of post-immunotherapy nephrectomy specimens a single-institution experience of 70 cases. Diagnostic Histopathology 30(5):275-281, 2024. e-Pub 2024.
2. Zhang M, Pettaway C, Vikram R, Tamboli P. Adenoid cystic carcinoma of the urethra/Cowper's gland with concurrent high-grade prostatic adenocarcinoma: a detailed clinicopathologic case report and review of the literature. Hum Pathol 58:138-144, 2016. e-Pub 2016. PMID: 27554206.
3. Tamboli V, Mishra GP, Mitrat AK. Polymeric vectors for ocular gene delivery. Ther Deliv 2(4):523-36, 2011. e-Pub 2011. PMID: 21858246.
4. Mishra GP, Tamboli V, Jwala J, Mitra AK. Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis. Recent Pat Inflamm Allergy Drug Discov 5(1):26-36, 2011. e-Pub 2011. PMID: 21171952.
5. Adeniran AJ, Tamboli P. Clear cell adenocarcinoma of the urinary bladder: a short review. Arch Pathol Lab Med 133(6):987-91, 2009. e-Pub 2009. PMID: 19492895.
6. Vikram R, Ng CS, Tamboli P, Tannir NM, Jonasch E, Matin SF, Wood CG, Sandler CM. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics 29(3):741-54; discussion 755-7, 2009. e-Pub 2009. PMID: 19448113.
7. Ng CS, Wood CG, Silverman PM, Tannir NM, Tamboli P, Sandler CM. Renal cell carcinoma: diagnosis, staging, and surveillance. AJR Am J Roentgenol 191(4):1220-32, 2008. e-Pub 2008. PMID: 18806169.
8. Tamboli P, Toprani TH, Amin MB, Ro JS, Ordóñez NG, Ayala AG, Ro JY. Carcinoma of lung with rhabdoid features. Hum Pathol 35(1):8-13, 2004. e-Pub 2004. PMID: 14745719.

Professional Educational Materials

1. Tamboli P, Troncoso P. Grossing of the Genitourinary tract: Surgical pathology grossing manual. M. D. Anderson Cancer Center, 2019.
2. Tamboli P. Autopsy manual. M. D. Anderson Cancer Center, 2019.

Other Articles

1. Ricketts, CJ, de Cubas, AA, Fan, H, Smith, CC, Lang, M, Reznik, E, Bowlby, R, Gibb, EA, Akbani, R, Beroukhim, R, Bottaro, D, Choueiri, TK, Gibbs, RA, Godwin, AK, Haake, S, Hakimi, AA, Henske, EP, Hsieh, JJ, Ho, TH, Kanchi, R, Krishnan, B, Kwiatkowski, DJ, Liu, W, Merino, M, Mills, GB, Myers, J, Nickerson, ML, Reuter, VE, Schmidt, LS, Shelley, CS, Shen, H, Shuch, B, Signoretti, S, Srinivasan, R, Tamboli, P, Thomas, GV, Vincent, BG, Vocke, C, Wheeler, DA, Yang, L, Kim, WY, Robertson, AG, Spellman, P, Rathmell, WK, Linehan, WM Erratum. Cell Reports 43(4), 2024. PMID: 38578829.
2. Cowman, SJ, Fuja, D, Liu, X, Tidwell, R, Kandula, N, Sirohi, D, Agarwal, AM, Emerson, L, Tripp, SR, Mohlman, JS, Stonhill, M, Garcia, G, Conley, CJ, Olalde, AA, Sargis, T, Ramirez-Torres, A, Karam, JA, Wood, CG, Sircar, K, Tamboli, P, Boucher, K, Maughan, B, Spike, BT, Ho, TH, Agarwal, N, Jonasch, E, Koh, MY Macrophage HIF-1a Is an independent prognostic indicator in kidney cancer. Clinical Cancer Research 27(11):3265, 2021. PMID: 34074655.

Abstracts

1. Ebare K, Wang G, Wang Q, Nair V, Iyer S, Rao P, Tamboli P, Kannan K, Wang J, Karam J, Soleimani M, Bhat K, Sircar K. Spatial Transcriptomic Evaluation of Tumor And Tumor Microenvironment of Renal Cell Carcinoma With Respect To Regional Histology And Response To Immunotherapy. Mod Pathol 104(3):S940-42, 2024. e-Pub 2024.
2. Kumar G, Ruiz-Cordero R, Akgul M, Murugan P, Shen S, Brimo F, Rao P, P T, Creighton C, Bhat K, Karam J, Kannan K, Sircar K. Gene Expression Signatures From FFPE Kidney Tumor Samples Can Predict For Clinically Indolent Renal Oncocytic Tumors. Mod Pathol 104(3):S982-83, 2024. e-Pub 2024.
3. Mohanty S, Paner G, Lobo A, Parwani A, Sangoi A, Delahunt B, Manini C, Luthringer D, Sirohi D, Midha D, Maclean F, Giannico G, Martignoni G, Al-Ahmadie H, Moch H, Gandhi J, Srigley J, Epstein J, Lopez J, Trpkov K, Cheng L, Browning L, Akgul M, Aron M, Picken M, Tretiakova M, Hirsch M, Varma M, Kuroda N, Gupta N, Tamboli P, Rao P, Mehra R, Desai S, Menon S, Williamson S, Kaushal S, Jha S, Kandukuri S, Rao BV, Amin M. Uropathologists’ Perspectives on Utilization of Key Morphologic and Molecular Parameters in Urothelial, Renal, and Prostatic Cancers Based on Clinical Practice Guidelines. Mod Pathol:639-640, 2022. e-Pub 2022.
4. Shen SS, Guo CG, Ro JY, Anton R, Cheng L, Hameed O, Truong LD, Huang J, Weiss MA, Lin F, Srigley JR, McKenney JK, Tamboli P, Grignon DJ, Jimenez RE, Zhou M, Paner GP, Troncoso P, Amin MB, Ayala AG. Common Diagnostic Problems in Interpretation of Early Invasive Bladder Cancer: A Consensus Study. Mod Pathol 24(1s):224A, 2011. e-Pub 2011.
5. Rao P, Tamboli P. Immunohistochemical Expression of OCT 3/4 in Renal Medullary Carcinoma – A Potential Diagnostic Pitfall. Mod Pathol 24(1s):219A, 2011. e-Pub 2011.
6. Monzon FA, Alvarez K, Peterson L, Sircar K, Tamboli P, Jonasch E. Chromosomal Imbalances Identify Pathways Associated with Resistance to Antiangiogenic Therapy in Clear Cell Renal Cell Carcinoma. Mod Pathol 24(1s):212A, 2011. e-Pub 2011.
7. Herrera LP, Amin M, Schwartz JD, Shen SS, Hansel DE, Paner GP, Tamboli P, Arora K, Annaiah C, Parakh RS, Amin MB. Detailed Immunohistochemical Characterization in the Spectrum of Sex Cord Stromal Tumors (SCST) of the Testis Using Novel and Established Immunohistochemical (IHC) Markers: A Study of 41 Cases. Mod Pathol 24(1s):197A, 2011. e-Pub 2011.
8. Herrera LP, Hes O, Hirsch M, Comperat E, Camparo P, Rao P, Picken M, Montironi V, Annaiah C, Arora K, Tamboli P, Westfall DE, Monzon FA, Amin MB. Clear Cell-Papillary Renal Cell Carcinoma (CP-RCC) Not Associated with End Stage Renal Disease: Clinicopathologic Analysis of 50 Tumors Confirming a Novel Subtype of Renal Cell Carcinoma (RCC) Occurring in a Sporadic Setting. Mod Pathol 24(1s):197A, 2011. e-Pub 2011.
9. Behdad A, Monzon FA, Hes O, Hirsch M, Michal M, Comperat E, Camparo P, Rao P, Picken M, Montironi R, Annaiah C, Herrera LP, Arora K, Westfall DE, Tamboli P, Amin MB. Relationship between Sporadic Clear Cell-Papillary Renal Cell Carcinoma (CP-RCC) and Renal Angiomyoadenomatous Tumor (RAT) of the Kidney: Analysis by Virtual-Karyotyping, Fluorescent In Situ Analysis and Immunohistochemistry (IHC). Mod Pathol 24(1s):179A, 2011. e-Pub 2011.
10. Chaux A, Tamboli P, Ayala A, Soares F, Rodríguez I, Barreto J, Cubilla AL. Warty-basaloid carcinoma: clinicopathological features of a distinctive penile neoplasm. Report of 45 cases. Mod Pathol 23(6):896-904, 2010. e-Pub 2010. PMID: 20305615.
11. Si Q, Stanton M, Tamboli P, Czerniak BA, Guo CG. Primary Small Cell Carcinoma of the Renal Pelvis: A Report of 11. Mod Pathol 23(1s):219A, 2010. e-Pub 2010.
12. Monzon FA, Alvarez K, Sircar K, Tamboli P, Jonasch E. Virtual Karyotyping with SNP Arrays Identifies Chromosomal. Mod Pathol 23(1s):208A, 2010. e-Pub 2010.
13. Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, Iczkowski KA, McKenney JY. Interobserver Reproducibility (IOR) in the Diagnosis of Invasive. Mod Pathol 23(1s):216A, 2010. e-Pub 2010.
14. Plimack ER, Jonasch E, Bekele BN, Qiao W, Tamboli P, Ng CS, Tannir NM. Sunitinib in papillary renal cell carcinoma (pRCC): Results from a single-arm phase II study. 2010 Genitourinary Cancers Symposium, 2010. e-Pub 2010.
15. Choueiri TK, Dubauskas Lim Z, Jonasch E, Hirsch MS, Tamboli P, Vaishampayan UN, McDermott DF, Heng DY, Tannir NM. Vascular endothelial growth factor (VEGF)-targeted therapy for the treatment of adult patients (pts) with metastatic TFE-3 positive translocation renal cell carcinoma (RCC). 2010 Genitourinary Cancers Symposium, 2010. e-Pub 2010.
16. Monzon FA, Alvarez K, Amato RJ, Peterson L, Shen SS, Hernandez-McClain J, Sircar K, Tamboli P, Tannir NM, Jonasch E. Chromosomal imbalances as biomarkers for recurrence and antiangiogenic resistance in clear cell renal cell carcinoma. J Clin Oncol, 2010 ASCO Annual Meeting 28, 2010. e-Pub 2010.
17. Choueiri TK, Lim ZD, Hirsch MS, Tamboli P, Jonasch E, McDermott DF, Dal Cin P, Corn P, Vaishampayan U, Heng DY, Tannir NM. Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma. J Clin Oncol 28(15s), 2010. e-Pub 2010.
18. Jonasch E, Tsavachdidou D, Wood CG, Matin SF, Corn PG, Tamboli P, Wang X, Tannir N. Phase II presurgical study of bevacizumab plus erlotinib in untreated patients with metastatic renal cell carcinoma. J Clin Oncol, 2009 ASCO Annual Meeting 27(15s), 2009. e-Pub 2009.
19. Margulis V, McDonald M, Matin SF, Tamboli P, Swanson DA, Wood CG. Predictors of oncologic outcome after resection of locally recurrent renal cell carcinoma. 2009 Genitourinary Cancers Symposium, 2009. e-Pub 2009.
20. Jonasch E, Wood CG, Matin S, Tamboli P, Do K, Pagliaro LC, Aparicio AM, Araujo JC, Tannir NM. Presurgical bevacizumab in patients with metastatic clear cell renal cell carcinoma: A phase II study. 2008 ASCO Annual Meeting, 2008. e-Pub 2008.
21. Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CG. Insight into the natural history of surgically managed papillary renal cell carcinoma based on analysis of clinicopathologic predictors of oncologic outcome. 2008 Genitourinary Cancers Symposium, 2008. e-Pub 2008.
22. Punar M, Guo C, Tamboli P, Czerniak BA. Somatic Transformation to Sarcoma in Testicular Germ Cell Tumors: A Clinicopathologic Analysis of 33 Cases. Mod Pathol 21((Suppl 1)):177A, 2008. e-Pub 2008.
23. Antic T, Margulis V, Wood CG, Tamboli P. Margin Assessment of Partial Nephrectomy Specimens: Analysis of 200 Cases. Mod Pathol 21((Suppl 1)):145A, 2008. e-Pub 2008.
24. Luiña Contreras A, Tamboli P, Czerniak BA, Guo C. Primary Mediastinal Germ Cell Tumors with Somatic Transformation to Angiosarcoma: A Report of 9 Cases. Mod Pathol 21((Suppl 1)):346A, 2008. e-Pub 2008.
25. Gomez EM, Tamboli P, Czerniak BA, Guo C. Non-Bilharzial Squamous Cell Carcinoma of the Urinary Bladder: A Clinicopathological Study of 16 Cases. Mod Pathol 21((Suppl 1)):158A, 2008. e-Pub 2008.
26. Adeniran AJ, Tamboli P, Czerniak BA. Immunohistochemical Profile of Primary Urethral Carcinomas: Analysis of 60 Cases of Different Tumor Types. Mod Pathol 21((Suppl 1)):143A, 2008. e-Pub 2008.
27. Zhou Z, Sotelo EP, Tamboli P, Czerniak BA, Guo C. Choriocarcinoma in the Testis: A Clinicopathological Study of 65 Cases. Mod Pathol 21((Suppl 1)):194A, 2008. e-Pub 2008.
28. Margulis V, Matin SF, Tamboli P, Swanson DA, Wood CG. Surgical morbidity associated with administration of targeted molecular therapies prior to cytoreductive nephrectomy for metastatic renal cell carcinoma. J Urol 179((Suppl. S)):213A, 2008. e-Pub 2008.
29. Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CG. Prognostic features of pathologic stage T3 renal cell carcinoma: proposal for revision of current primary tumor classification. J Urol 177((Suppl. S)):901A, 2007. e-Pub 2007.
30. Adeniran AJ, Tamboli P, Spiess PE, Grossman HB, Dinney CPN, Czerniak BA. Primary Carcinomas of the Urethra: A Clinicopathologic Analysis of 100 Patients. Mod Pathol 20((Suppl. 2)):133A, 2007. e-Pub 2007.
31. Nicolas MM, Wood CG, Tamboli P. Concurrent Renal Oncocytoma and Malignant Renal Tumors: Analysis of 28 Cases. Mod Pathol 20((Suppl. 2)):166A, 2007. e-Pub 2007.
32. Kassouf W, Sanchez-Ortiz R, Tamboli P, Jonasch E, Merchant MM, Matin SF, Swanson DA, Wood CG. Cytoreductive nephrectomy for metastatic renal cell carcinoma in the presence of non-conventional histology. J Urol 177((Suppl. S)):1109A, 2007. e-Pub 2007.
33. Matin S, Booth J, Ahrar K, Tamboli P, Wood C. Contemporary strategies for managing nonhereditary synchronous bilateral renal tumors and the impact of minimally invasive, nephron-sparing techniques. J Endourol 21((Suppl. 1)):A278, 2007. e-Pub 2007.
34. Zhu Y, Tamboli P, Wang Y, Wood CG, Wu X. BPDE-induced lymphocytic 3p aberrations and the genetic susceptibility to renal cell carcinoma. Proc Amer Assoc Cancer Res 47, 2006. e-Pub 2006.
35. Kassouf W, Sanchez-Ortiz R, Tamboli P, Matin S, Swanson D. Cytoreductive nephrectomy for metastatic renal cell carcinoma in the presence of non-conventional histology. J Clin Oncol, ASCO Annual Meeting Proceedings 18S, 2006. e-Pub 2006.
36. Sanchez-Ortiz R, Tamboli P, Lozano ML, Matin S, Wood CG. Adjuvant thalidomide improves disease specific survival for patients with renal cell carcinoma at high risk for relapse following surgery. J Clin Oncol,ASCO Annual Meeting Proceedings 18S, 2006. e-Pub 2006.
37. Shen SS, Ro JY, Tibbs RF, Truong LD, Zhai Q, Jung SJ, Tamboli P, Ordonez NG, Ayala AG. Mucinous Tubular and Spindle Cell Carcinoma of Kidney: Histologic and Immunohistochemical Features Favoring Proximal Nephron Differentiation. Lab Invest 86((Suppl 1)):160A, 2006. e-Pub 2006.
38. Tamboli P, Burt KL, Wood CG, Czerniak BA. Papillary Adenoma(s) in Renal Resection Specimens: Incidence and Relationship to Renal Neoplasia. Lab Invest 86((Suppl 1)):164A, 2006. e-Pub 2006.
39. Tamboli P, Tibbs RF, Sanchez-Ortiz RF, Wood CG, Vakar-Lopez F. Needle Tract Seeding of Perinephric Adipose Tissue Following Imaging-Guided Biopsy of Renal Tumors. Lab Invest 86((Suppl 1)):164A, 2006. e-Pub 2006.
40. Jonasch E, Thomas CK, Tamboli P, Wen S, McDonnell T. Concordance between PTEN and p27 staining in primary and metastatic tumor samples in a renal carcinoma tissue microarray. Proc Am Assoc Cancer Res 46:3092A, 2005. e-Pub 2005.
41. Tamboli P, Copland JA, Wood CG. Transforming Growth Factor-β Receptor Expression in Clear Cell Renal Cell Carcinoma. Mod Pathol 18:166A, 2005. e-Pub 2005.
42. Gomez JA Tamboli P. Reporting of Testicular Germ Cell Tumors: Are the Clinically Relevant Data in the Pathology Report? . Mod Pathol 18:142A, 2005. e-Pub 2005.
43. Harik LR, Pashaei S, Humphrey PA, Tamboli P, Amin MB. Needle Core Biopsy of the Kidney for Mass Lesions: A Clinicopathologic Perspective Based on 196 Cases. Mod Pathol 18:144A, 2005. e-Pub 2005.
44. Sanchez-Ortiz R, Luongo T, Tamboli P, Madsen L, Swanson DA, Wood CG. Increased incidence of benign histology in elderly patients with renal masses. J Urol 173 (Suppl):1404A, 2005. e-Pub 2005.
45. Choi WL, Amin MB, Tamboli P, Eble JN, Young RH. Glandular Neoplasms of the Urachus: Clinicopathologic and Immunohistochemical Analysis of 43 Cases with Special Emphasis on Low-Grade Mucinous Cystic Tumors. Mod Pathol 18:134A, 2005. e-Pub 2005.
46. Tamboli P, Mathew P, Bekele BN, Prieto VG. Expression of MAP Kinase and Akt in Clear Renal Cell Carcinoma (RCC), Including Sarcomatoid RCC. Mod Pathol 18:166A, 2005. e-Pub 2005.
47. Copland JA, Maity T, LeGrand SN, Tamboli P, Taormina J, Wood CG. Transforming growth factor ß type III receptor is a tumor suppressor gene in conventional renal cell carcinoma. J Urol 171 (Suppl):1022A, 2004. e-Pub 2004.
48. Skinnider BF, Folpe AL, Hennigar RA, Lim SD, Cohen C, Tamboli P, dePeralta-Venturina M, Amin MB. Adult renal epithelial neoplasms (RENs) have distinct and diagnostically useful cytokeratin (CK) profiles. Mod Pathol 17:178A, 2004. e-Pub 2004.
49. Adsay NV, Che M, Basturk O, Tamboli P, Sakr W, Amin M, Grignon DJ. Sarcomatous transformation in mixed epithelial stromal tumors of the kidney (malignant MEST). Mod Pathol 17:135A, 2004. e-Pub 2004.
50. Ayala AG, Tibbs RF, Tamboli P, Troncoso P. High-grade prostatic intraepithelial neoplasia (PIN) like lesion: A possible embryologic remnant mimicking carcinoma. Mod Pathol 17:138A, 2004. e-Pub 2004.
51. Molina JT Tamboli P. Immunohistochemical expression of CD10, cytokeratin and vimentin in conventional (Clear) renal cell carcinoma with sarcomatoid dedifferentiation: A comparative study of 60 cases. Mod Pathol 17:168A, 2004. e-Pub 2004.
52. Salama ME, de Peralta-Venturina M, Guru K, Peterson E, Stricker H, Javidan J, Peabody J, Amin M, Tamboli P, Menon M, Amin MB. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of renal tumors. Lab Invest 83:168A, 2003. e-Pub 2003.
53. Sakr W, Grignon D, Srigley J, Troncoso P, Tamboli P, Lopes-Corona E, Reuter V. Recent trends regarding the significance of isolated high grade prostatic intraepithelial neoplasia (HGPIN) in predicting prostate cancer (PCA) on follow up biopsies: is there a change in confirming cancer diagnosis? A multi institutional study. Lab Invest 83:168A, 2003. e-Pub 2003.
54. Tamboli P, Abrahams NA, Wright ET, Ro JY, Ayala AG. Metastases to the kidney: a clinicopathologic analysis of 50 cases. Lab Invest 83:172A, 2003. e-Pub 2003.
55. Tamboli P, Abrahams NA, Troncoso P. High-grade prostatic intraepithelial neoplasia (HGPIN) in needle biopsy (Nbx): does routine use of recuts help in detecting prostatic adenocarcinoma (PCa)? . Lab Invest 83:172A, 2003. e-Pub 2003.
56. Abrahams NA, Slaton JW, Wood CG, Ayala AG, Tamboli P. Eosinophilic cells in conventional renal cell carcinoma (CRCC): observations in 100 cases and implications for Fuhrman nuclear grading (FNG). Lab Invest 83:139A, 2003. e-Pub 2003.
57. Sloper D, McGee S, Anderson K, Tamboli P, Swanson DA, Dinney C, Slaton JW. A comparison of organ-specific progression-related gene expression between resected human renal cell carcinoma (RCC) metastases and spontaneous metastases derived from an orthotopic murine model of RCC. J Urol 169(Suppl):141, 2003. e-Pub 2003.
58. Tamboli P, Prieto VG, Bekele BN, Mathew P. The tyrosine kinase receptor c-Kit is over expressed in sarcomatoid renal carcinomas. Proceedings of the Annual Meeting of the American Society of Clinical Oncology, 2003. e-Pub 2003.
59. Kim MK, Tamboli P, Ro JS, Ayala AG, Ordonez NG, Ro JY. Malignant pleural mesothelioma with lymph node metastasis. Lab Invest 82:322A, 2002. e-Pub 2002.
60. Vakar-Lopez F, Zhang S, Tamboli P, Ro JS, Ayala AG, Ro JY. Hyperplastic muscularis mucosae of the urinary bladder: a study of 102 cystectomy and 17 autopsy specimens. Lab Invest 82:185A, 2002. e-Pub 2002.
61. Huang S, Tamboli P, Hester G, Pettaway CA. Genital malignant melanoma: The M. D. Anderson Cancer Center experience. J Urol 167(Suppl):153, 2002. e-Pub 2002.
62. Khoury JD, Huaringa AJ, Tamboli P, Ayala AG, Ro JY. Gallium-67 scintigraphy scan in the assessment of diffuse interstitial lung diseases: a pathologic correlation. Lab Invest 82:322A, 2002. e-Pub 2002.
63. Varma M, Morgan M, Tamboli P, Jasani B, Amin MB. Sensitivity of prostate specific antigen immunohistochemistry in poorly differentiated prostate cancer. Lab Invest 82:185A, 2002. e-Pub 2002.
64. Kim MK, Tamboli P, Ro JS, Ayala AG, Ro JY. Utility of frozen-section in pulmonary lesions. Lab Invest 82:322A, 2002. e-Pub 2002.
65. Sawh RN, Tamboli P, Ayala AG, Ro JY. Second opinion review of pleuropulmonary pathology: findings from a cancer center. Lab Invest 82:329A, 2002. e-Pub 2002.
66. Kedar D, Izawa J, Tamboli P, Ainslie N, Eddings T, Babaian RJ, Dinney CPN, Pisters LP, Pettaway CA. Intraoperative lymphatic mapping (IOLM) for squamous penile cancer: the M. D. Anderson Cancer Center prospective experience. J Urol 165(Suppl):173, 2001. e-Pub 2001.
67. Gomez JA, Tamboli P, Slaton JW, Ro JY, Ayala AG. Urothelial Carcinoma (UC) of the Upper Urinary Tract: A Clinico Pathologic Study of 70 Cases from 1985 to 2000. Mod Pathol 14:109A, 2001. e-Pub 2001.
68. Inoue K, Kamada M, Slaton JW, Fukata S, Yoshikawa C, Tamboli P, Dinney CP, Shuin T. The prognostic value of angiogenic and metastasis-related genes for progression for renal pelvis and ureter cancer. J Urol 165(Suppl):280, 2001. e-Pub 2001.
69. Lim SD, Amin M, DePeralta-Venturina M, Tamboli P, Ro JY, Slaton JW, Jiminez RE, Amin MB. Patterns of Metastasis and Metastatic Potential of Histologic Subtypes of Renal Cell Carcinoma (RCC): A Study of 209 Clinical Cases. Mod Pathol 14:115A, 2001. e-Pub 2001.
70. Copeland JN, Amin MB, Humphrey PA, Tamboli P, Ro JY. Morphologic Patterns of Prostatic Adenocarcinoma (PCa) Metastatic to the Lung. Mod Pathol 14:217A, 2001. e-Pub 2001.
71. Tamboli P, Amin MB, Eble JN, Young RH. Histologic Spectrum of Glandular Neoplasms of the Urachus, with Special Emphasis on Low-Grade Tumors. Mod Pathol 14:124A, 2001. e-Pub 2001.
72. Tamboli P, Troncosco P, Johnston DA, Ro JY, Ayala AG. Gleason Grading of Needle Biopsies (NBx): Are We There Yet? . Mod Pathol 14:124A, 2001. e-Pub 2001.
73. Slaton JW, Inoue K, Tamboli P, El-Naggar AK, Swanson DA, Dinney CP. Effect of organ site on expression of progression-related genes in resected renal cell carcinoma (RCC) metastases. J Urol 165(Suppl):128, 2001. e-Pub 2001.
74. Amin MB, Moch H, Alvarado-Cabrero I, Jiminez RE, Tamboli P, DePeralta-Venturina M, Amin M, Lim SD, Mihatsch M, Stricker H. Chromophobe Renal Cell Carcinoma (CH-RCC): Histopathologic and Prognostic Features in 116 Cases. Mod Pathol 14:100A, 2001. e-Pub 2001.
75. Ptaszynksi K, Tamboli P, Ro JY, Ayala AG. Cartilaginous Tumors of the Hand: Proposal for a New Classification System. Mod Pathol 14:17A, 2001. e-Pub 2001.
76. Amin M, Tamboli P, Ayala AG, Ro JY. Adenocarcinoma of Lung with Micropapillary Component: A Histologic Feature Possibly Indicating Poor Prognosis. Mod Pathol 14:216A, 2001. e-Pub 2001.
77. SF-Y H, Slaton JW, Tamboli P, Song R, Kedar D, Sweeney P, Mian B, Pettaway CA. Development and characterization of a novel orthotopic model of penile squamous carcinoma in nude mice. Proceedings of the 92nd Annual Meeting of the American Association of Cancer Research 42:914, 2001. e-Pub 2001.
78. de Peralta-Venturina M, Amin MB, Zavala-Pompa A, Cohen C, Amin M, Tamboli P, Ro JY. Profile of cyokeratin subsets in a wide spectrum of adult renal epithelial neoplasms. Mod Pathol 13:98A, 2000. e-Pub 2000.
79. Tamboli P, Amin MB, Mohsin SK, Ben-Dor D, Lopez-Beltran A. Plasmacytoid variant of non-papillary urothelial carcinoma. Mod Pathol 13:116A, 2000. e-Pub 2000.
80. Amin M, Barnabas N, de Peralta-Venturina M, Pindolia K, Nanavati R, Tamboli P, Amin MB, Worsham M. Mutational analysis of Von-Hippel Lindau (VHL) gene in adult renal epithelial neoplasms with abundant granular cytoplasm. Mod Pathol 13:92A, 2000. e-Pub 2000.
81. Tamboli P, Tran TA, Ro JY, Ayala AG, Ayala G, Amin MB, Velazques E, Cubilla AL. Mixed basaloid-condylomatous (warty) squamous cell carcinoma of penis: A report of 17 cases. Mod Pathol 13:115A, 2000. e-Pub 2000.
82. Slaton JW, Inoue K, Morgenstern N, Tamboli P, Ayala AG, Dinney CPN, Pettaway CA. Metastasis-related gene expression predicts for positive inguinal lymph nodes in squamous penile carcinoma. J Urol 163(Suppl):144, 2000. e-Pub 2000.
83. Moore RJ, Tamboli P, Ordonez NG, Amin MB, Zavala-Pompa A, Ro JY, Ayala AG. Immunohistochemical expression of thrombomodulin in renal collecting duct carcinoma and invasive urothelial carcinoma of the renal pelvis. Mod Pathol 13:108A, 2000. e-Pub 2000.
84. Cubilla AL, Tamboli P, Amin MB, Velazquez E, Ro JY, Ayala AG. Geographical comparison of subtypes of penile squamous cell carcinoma from regions of high and low incidence. Mod Pathol 13:97A, 2000. e-Pub 2000.
85. Jimenez RE, Amin MB, Eble JN, Reuter VE, Epstein JI, Folpe AL, dePeralta M, Tamboli P, Ansell ID, Grignon DJ, Young RH. Concurrent angiomyolipoma and adult renal epithelial neoplasia: A study of 33 cases. Mod Pathol 13:103A, 2000. e-Pub 2000.
86. Che M, Tamboli P, Amato RJ, Ro JY, Ayala AG. Bilateral testicular germ cell tumors: 20-year experience at a cancer center. Mod Pathol 13:95A, 2000. e-Pub 2000.
87. Tran TA, Tamboli P, Ayala G, Ro JY, Ayala AG, Cubilla AL. Basaloid squamous carcinoma of the penis: A clinico-pathologic study of 11 cases. Mod Pathol 13:117A, 2000. e-Pub 2000.
88. Slaton JW, Inoue K, Tamboli P, El-Naggar AK, Swanson DA, Dinney CPN. Progression-related gene expression in resected renal cell carcinoma lung metastases. J Urol 136(Suppl):115, 2000. e-Pub 2000.
89. Javidan J, Tewari A, Stricker HJ, Amin M, Tamboli P, Peabody JO, Amin MB, Menon M. Genetic adaptive model to predict survival in 341 patients diagnosed with renal cell carcinoma. J Urol 163((Suppl.)):156A, 2000. e-Pub 2000.

Book Chapters

1. Menon S, Alvarado-Cabrero I, Tamboli P. Differentiated penile intraepithelial neoplasia, HPV-independent. In: WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. 5. International Agency for Research on Cancer (IARC), 369-371, 2022.
2. Tamboli P, Alvarado-Cabrero I, Canete Portillo S, Zynger DL. Penile adenosquamous and mucoepidermoid carcinomas. In: WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. 5. International Agency for Research on Cancer (IARC), 380, 2022.
3. Tamboli P, Alvarado-Cabrero, I, Velazquez EF. Condyloma acuminatum. In: WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. 5. International Agency for Research on Cancer (IARC), 364-3659789283245124, 2022.
4. Harper DM, Alavarado-Cabrero I, Tamboli P. Penile intraepithelial neoplasia, HPV-associated. In: WHO Classifications of Tumours Editorial Board. Urinary and male genital tumours. 5. International Agency for Research on Cancer (IARC), 366-368, 2022.
5. Alvarado-Cabrero I, Chaux A, Muneer A, et al. HPV-associated squamous cell carcinoma. In: WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. 5. International Agency for Research on Cancer (IARC), 372-374, 2022.
6. Cheville J, Lopez-Beltran A, Montironi R, et al. Metastasis to the kidney. In: WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. 5. International Agency for Research on Cancer (IARC), 457-458, 2022.
7. Tamboli P, i A, Canete Portillo S, et al. Extramammary Paget disease. In: WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. 5. International Agency for Research on Cancer (IARC), 381-382, 2022.
8. Hwang, M, Tamboli, P. Mesenchymal tumors. In: Urinary Bladder Pathology, 97-111, 2021.
9. Rao P, Perrino CM, Zynger DL, Jorda M, Tamboli P, Sanchez DF, Cubilla AL, Iczkowski K, Zhang M, Sircar K. Genitourinary pathology. In: Oncological Surgical Pathology. 1st. Springer, 1523-1728, 2020.
10. Nagarajan P, Euscher ED, Tamboli P, Prieto VG. Miscellaneous lesions of the vulva and penis. In: Gynaecologic and Urologic Pathology. Similarities, Differences and Challenges. 1st. Cambridge University Press, 2019.
11. Nagarajan P, Euscher ED, Tamboli P, Prieto VG. Malignant Neoplasms of the Vulva and the Penis. In: Gynaecologic and Urologic Pathology. Similarities, Differences and Challenges. 1st. Cambridge University Press, 2019.
12. Grignon DA, Cheville J, Ro JY, Tamboli P. Adenocarcinoma of Urinary Bladder. In: WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th. WHO PRESS, 2016.
13. Ayala AG, Ro JY, Tamboli P. Melanocytic Lesions of Penis. In: WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th, 2016.
14. Landman J, Duddalwar V, Amin MB, Aron M, Cadeddu J, Coy H, Lall C, Nelson K, Okhunov Z, Raman S, Tamboli P. Follow-up evaluation after focal ablation of renal masses. In: Image-guided therapies for prostate and kidney cancer. 1st. Société Internationale d’Urologie-International Consultation on Urological Diseases, 591-619, 2016.
15. Cubilla AL, Amin MB, Ayala A, Ayala G Caux A, Corbishely C, Dilner J, Moch H, Sanchez DF, Soares, FA, Tamboli P, Young RH. Squamous carcinoma of penis. In: WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th. WHO PRESS, 2016.
16. Rao P, Tamboli P. Mesenchymal Lesions Of The Urinary Bladder. In: Advances in Surgical Pathology: Bladder Cancer. 1st. Wolters Kluwer, 177-194, 2016.
17. Sircar K, Tamboli P. Pathologic Considerations. In: Kidney Cancer: Principles and Practice. 2nd. Springer, 17-30, 2015.
18. Rao P, Tamboli P. Pathology of Penile Cancer and its Precursor Lesions. In: Penile Cancer: Diagnosis and Treatment. 1st. Springer, 43-64, 2013.
19. Abrahams NA, Tamboli P. Epithelial neoplasms of the renal cortex. In: Practical renal patology: A Diagnostic Approach. 1st. Elsevier, 227-68, 2013.
20. Shen S, Adeniran AJ, Tamboli P. Non-Epithelial Neoplasms of the Kidney. In: Practical Renal Pathology: A Diagnostic Approach. 1st. Elsevier, 269-90, 2013.
21. Sircar K, Tamboli P. Pathologic Considerations. In: Kidney Cancer-Principles and Practice. 1st. Springer-Verlag, 17-28, 2012.
22. Tickoo SK, Tamboli P, Amin MB. Testis and epididymis. In: Modern Surgical Pathology. 2nd. Weidner N, Cote RJ, Suster S, Weiss LM, Saunders WB, 1197-1236, 2009.
23. Tamboli P, Cubilla AL, Amin MB. Penis and scrotum. In: Modern Surgical Pathology. 2nd. W.B. Saunders, 1181-1196, 2009.
24. Matin S, Tamboli P, Wood CG. Renal Angiomyolipoma: Diagnosis and Management. In: Clinical Management of Renal Tumors. 1st. Humana Press, 565-586, 2008.
25. Tamboli P, Gomez JA, Jimenez R. Systemic oncology of the urinary tract. In: Cancer Handbook. 2nd. Macmillan Reference, 666-683, 2007.
26. Ayala AG, Tamboli P. Melanocytic lesions of the penis. In: Pathology and genetics of tumors of the urinary system and male genital organs. 3rd. IARCPress, 291, 2004.
27. Ayala AG, Tamboli P, El-Bolkainy MN, Schoenberg MP, Oliva E, Sidransky D, Cairns P. Adenocarcinoma of the urinary bladder. In: Pathology and genetics of tumors of the urinary system and male genital organs. 3rd. IARC Press, 128-130, 2004.
28. Tamboli P. Hemangioma of Kidney. In: Pathology and genetics of tumors of the urinary system and male genital organs. 3rd. IARC Press, 71, 2004.
29. Lopez-Beltran A, Sauter G, Gasser T, Hartmann A, Schmitz-Dräger BJ, Helpap B, Ayala AG, Tamboli P, Knowles MA, Sidransky D, Cordon-Cardo C, Jones PA, Cairns P, Simon R, Amin MB, Tyczynski JE. Infiltrating urothelial carcinoma of the urinary bladder. In: Pathology and genetics of tumors of the urinary system and male genital organs. 3rd. IARC Press, 93-109, 2004.
30. Ayala AG, Tamboli P. Urachal carcinoma. In: Pathology and genetics of tumors of the urinary system and male genital organs. 3rd. IARC Press, 131, 2004.
31. Tamboli P, Ro JY. Mesenchymal tumors of the urinary bladder. In: Pathology of the Urinary Bladder. 1st. Saunders, 145-162, 2004.
32. Tickoo SK, Tamboli P, Warner NE, Amin MB. Testis and epididymis. In: Modern Surgical Pathology. 1st. W.B. Saunders, 1215-1256, 2003.
33. Amin MB, Tamboli P, Cubilla AL. Penis and scrotum. In: Modern Surgical Pathology. 1st. W.B. Saunders, 1197-1214, 2003.
34. Tamboli P, Ro JY. Pathologic evaluation of lung cancer. In: Lung Cancer. 1st. Springer-Verlag, 57-80, 2003.
35. Tamboli P, Jimenez R, Amin MB. Systemic oncology of the urinary tract. In: Cancer Handbook. 1st. Macmillan Reference, 2002.
36. Amin MB, Tamboli P, Ro JY. Non-transitional cell carcinoma of the bladder. In: Bladder Cancer: Biology, Diagnosis and Management. 1st. Oxford University Press, 125-140, 1999.

Letters to the Editor

1. Rao P, Tamboli P. Do clear cell papillary renal cell carcinomas occur in patients with von Hippel-Lindau disease?-Reply. Hum Pathol 46: 341-3, 2015.
2. Guo CC, Shen SS, Si QS, Dancer J, Stanton ML, Tamboli P, Ro JY, Czerniak BA. Necrosis assessment in renal carcinoma-reply. Human Pathology 43: 151-52, 2012.
3. Amin MB Tamboli P. Impact of histologic subtyping of renal epithelial neoplasms: Author’s reply. Am J Surg Pathol 27: 1022-1024, 2003.